DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
01 feb 2011 - 08:21
Statutaire naam
DSM B.V.
Titel
DSM Announces Expiration of Waiting Period Under Hart-Scott-Rodino Act
Bericht
Royal DSM N.V. (NYSE Euronext: DSM KON), the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announced today the expiration of the mandatory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for its previously announced tender offer for all outstanding shares of common stock of Martek Biosciences Corporation (NASDAQ: MATK) at a price of $31.50 per share (the "Offer"). This condition of the Offer is thus satisfied.
Gerelateerde downloads
Datum laatste update: 21 maart 2026